PATENT CLAIM ANALYSIS

Application Number: 15744734
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["424", "133100"]

Abstract:
Provided are anti-GM-CSF antibodies or fragments thereof including humanized antibodies and fragments. Also provided are uses of the antibodies and fragments for therapeutic, diagnostic and prognostic purposes. Therapeutic uses of the antibodies and fragments, for example include the treatment of inflammatory and autoimmune diseases and disorders.

Claim (Index 1):
An isolated antibody or fragment thereof, wherein the antibody or fragment thereof has specificity to a human GM-CSF protein and comprises a VH CDR1 of SEQ ID NO: 1, a VH CDR2 of SEQ ID NO: 2, a VH CDR3 of SEQ ID NO: 3, a VL CDR1 of SEQ ID NO: 4, a VL CDR2 of SEQ ID NO: 5, and a VL CDR3 of SEQ ID NO: 6.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 86.0
- Lexical Diversity: 1.7
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11918368', '14718923', '12681396', '12766444', '13988498']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7774204745978582
- 35 USC 102 Novelty (BERT): 0.5398304988956844
- Combined Prediction Score: 0.7536614770276409
- Mean Citation Score: 373.708054
- Max Citation Score: 386.97614
- Similarity Product: 308.8505221037257

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test